Off topic? Sort of! Gom NTEK!!! U.S. SEC probing banks

New Post Public Reply Private Reply Replies (0) Message Board
AlanC AlanC #68960
Off topic? Sort of! Gom NTEK!!!
U.S. SEC probing banks over possible mismanagement of ADRs: WSJ

REUTERS Mon Nov 7, 2016 | 1:54pm EST
https://goo.gl/2daWcy

The U.S. Securities and Exchange Commission is investigating whether big banks have been mishandling securities in the American Depositary Receipt (ADR) market, the Wall Street Journal reported on Monday.

The SEC has sent subpoenas to four banks over the issue - Bank of New York Mellon Corp (BK.N), Citigroup Inc (C.N), Deutsche Bank AG (DBKGn.DE) (DB.N) and JPMorgan Chase & Co (JPM.N), the Journal reported, citing people close to the matter. (on.wsj.com/2eFTBJ4)

The probe, which is looking at whether the banks have broken controls designed to prevent market abuse and tax fraud, will not necessarily result in enforcement action, the report said.

A major focus of the SEC inquiry is the "pre-release" of ADRs, where banks issue depositary receipts to investors without first having the underlying shares in their custody, the Journal reported.

That means the shares could be sold short without actually having them - a practice known as "naked short selling", which is illegal.

ADRs represent shares of foreign companies that are held in custody by U.S. banks. Trading in ADRs rather than the underlying shares reduces administration and trading costs, both for companies and for investors.

Deutsche Bank and Citigroup declined to comment on the report, while the other two banks did not immediately respond to requests for comment.

(Reporting by Nikhil Subba in Bengaluru; Editing by Sai Sachin Ravikumar)

https://goo.gl/2daWcy

Nanotech Entertainment Inc. (NTEK) Stock Research Links

NTEK Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Stellar Elevates Leadership with Key Promotions to Drive Growth

Updated Category News Views 212

Stellar Strengthens Leadership Team for Future Success The new Executive Vice Presidents, Senior Vice President, and Vice Presidents will assume leadership roles this month. Stellar, an integrated design-build firm, proudly announces a strategic expansion of its leadership team, marking an important milestone in the company's ongoing growth and development. CEO Brian...

Continue Reading
Revolutionizing Fashion: Pixelz's Digital Twins Transform AI

Updated Category News Views 197

Transforming Fashion Content Creation Pixelz, a pioneering platform in fashion e-commerce content creation, has made headlines with its innovative approach to Artificial Intelligence (AI) featuring Digital Twins. This groundbreaking solution empowers brands to produce stunning, campaign-quality imagery rapidly and with creativity, thanks to a unique collaboration with...

Continue Reading
Alstom's First Half Results for Fiscal Year 2024/25 Unveiled

Updated Category News Views 212

Alstom's First Half Results Overview Alstom, a leading player in the transportation sector, recently shared significant updates regarding its performance in the first half of the fiscal year 2024/25. The presentation showcases their commitment to growth, innovation, and sustainability throughout the railway industry. Financial Highlights During this presentation, Alstom...

Continue Reading
Brooke Shields Leads 'Hearts of Heroes' Season 8

Updated Category News Views 10

A New Face Shines on 'Hearts of Heroes' Buckle up, folks! Brooke Shields is strapping in for the eighth season of 'Hearts of Heroes,' the award-winning show spotlighting everyday champions and first responders. Premiering on July 11, this series lands a spot in ABC's Weekend Adventure block, thrusting Shields into the limelight as she takes the baton from previous hosts...

Continue Reading
Cytokinetics' MYQORZO® Gains Approval for Hypertrophic Cardiomyopathy

Updated Category News Views 118

Cytokinetics' MYQORZO® Achieves NMPA Approval in China Cytokinetics, Incorporated (NASDAQ: CYTK) has exciting news—the approval of MYQORZO® (aficamten) by the China National Medical Products Administration (NMPA) for adults suffering from obstructive hypertrophic cardiomyopathy (oHCM). This milestone not only underscores the effectiveness of their innovative therapy...

Continue Reading